Alexander Roussanov discusses recent developments that make it
difficult and complex for medical device and pharmaceutical
companies to navigate the General Data Protection Regulation (GDPR)
in Europe. Regulators are scrutinizing every aspect of the data
processing activities of life sciences companies, including the
collection and use of clinical research data, advanced diagnostics,
wearables and more.
This is the latest in our series: "Insights: Life
Sciences" where we examine the legal issues and trends
impacting the life sciences and healthcare industries.
ยป See the rest of the "Insights: Life Sciences" series here.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
